Clinical trial
The Antiviral Efficacy of Entecavir in Chronic Hepatitis B Within the European Network of Excellence (VIRGIL)
NCT01323452 is registered in ClinicalTrials.gov with Foundation for Liver Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Antiviral Efficacy of Entecavir in Chronic Hepatitis B Within the European Network of Excellence (VIRGIL)
- Lead sponsor
- Foundation for Liver Research
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2010
- Completion date
- March 31, 2011
- Enrollment
- 418 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
entecavir for chronic hepatitis b patients